|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06078 HYGEIA HEALTH
Nominal 
17.560 +0.220 (+1.269%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 4,076,680 | 27.570% | 3,195,648 | 2,315,349 | 1,401,764 | 1,085,826 |
| Cost of Sales | (2,790,428) | 28.764% | (2,167,095) | (1,557,850) | (921,721) | (755,706) |
| Gross Profit | 1,286,252 | 25.055% | 1,028,553 | 757,499 | 480,043 | 330,120 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 856,087 | 33.075% | 643,311 | 572,845 | 252,612 | 79,320 | |
| Taxation | (171,139) | 6.011% | (161,435) | (119,642) | (75,551) | (39,553) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (2,020) | -60.330% | (5,092) | (11,746) | (6,976) | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 682,928 | 43.236% | 476,784 | 441,457 | 170,085 | 39,767 | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 33,017 | 40.438% | 23,510 | 20,930 | 47,672 | 94,887 |
| Depreciation & Amortisation | 210,542 | 37.447% | 153,181 | 114,447 | 77,540 | 71,282 |
| Directors' Emoluments | 9,919 | -21.558% | 12,645 | 6,032 | 3,858 | 6,192 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 108.000 | 40.260% | 77.000 | 71.000 | 38.000 | 14.000 |
| DPS (cts) | 0.000 | -- | 15.000 | 0.000 | 12.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | 19.481% | -- | 31.579% | -- |
| Cash flow per share ($) | 1.240 | -- | 1.111 | 0.690 | 0.663 | 0.826 |
| NBV per share ($) | 9.870 | -- | 8.000 | 7.211 | 6.906 | -- |
| Remarks: | Real time quote last updated: 15/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 384,571 |
| %Change | 15.094% |
| EPS / (LPS) | RMB 0.610 |
| NBV Per Share (¥) | RMB 10.493 |